Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FPAQN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,339
Award facts
- Contract value 100% obligated
- $8,339.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $8,339.18 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Xtandi 80 mg tablets (60-count units). The contract is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation. This award was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts with the DLA for branded and generic prescription medications, biologics, and specialized medical consumables. The company's contract portfolio demonstrates extensive experience delivering oncology treatments, immunology products, vaccines, and other prescription drugs directly to Department of Defense healthcare facilities. This particular delivery order for Xtandi, an oncology medication, reflects the company's ongoing role in providing essential pharmaceutical supplies to support military healthcare operations across the globe.
Quick answers
Who was awarded contract SPE2DB25FPAQN?
SPE2DB25FPAQN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FPAQN worth?
The government has obligated $8,339 on SPE2DB25FPAQN.
Is contract SPE2DB25FPAQN an order under another contract?
Yes. SPE2DB25FPAQN is a delivery order under SPE2DB25D9336, an indefinite delivery contract.
Was contract SPE2DB25FPAQN competed?
The extent of competition for SPE2DB25FPAQN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award